U.S. trial finds silver diamine fluoride arrested decay in over half of treated baby teeth
A U.S. Phase III trial of 830 children younger than 6 found that 38% silver diamine fluoride arrested decay in more than half of affected baby teeth when applied every six months. Painted onto cavities with a small sponge, the liquid avoids drilling, injections, and sedation but does not restore lost tooth material. The findings may support a future FDA application for cavity arrest, a use that remains off-label in the United States.
The story
A Phase III clinical trial, reported as published in JAMA Pediatrics, tested 38% silver diamine fluoride (SDF) in 830 children younger than 6 with severe early childhood caries. Participants were recruited through dental clinics, pediatric medical practices, and Head Start and Early Head Start programs in Michigan, New York, and Iowa. When clinicians applied the solution at six-month intervals, it arrested decay in more than half of affected baby teeth, according to the University of Michigan account. SDF is painted directly onto a cavity with a sponge-tipped applicator. Unlike a conventional filling, it does not remove decayed material or restore tooth structure; arresting decay means the existing damaged area stops deteriorating. The reported protocol did not require drilling, injections, anesthesia, or sedation. The source attributes its action to silver's antibacterial effects and fluoride's support for tooth mineral structure. The investigation began in 2018 and involved the University of Michigan, New York University, the University of Iowa, and Indiana University. The National Institute of Dental and Craniofacial Research provided more than $12 million in funding, and Elevate Oral Care supplied the tested Advantage Arrest 38% SDF product. The findings are intended to support an FDA application for using SDF to arrest dental caries.
Why it matters
Untreated cavities can progress to toothaches, infections, eating and sleep problems, missed school, and repeated medical appointments. The source says thousands of young children in the United States visit emergency departments for untreated cavities each year, while emergency clinicians generally cannot provide the dental procedures that address the underlying decay. A fast, non-sedating option could allow some cavities to be controlled while a child is connected with ongoing dental care, including when a pediatric medical visit occurs before a first dental appointment. It is a management option rather than a replacement for all restorative treatment.
Evidence and context
The source describes tooth decay as the most common chronic disease among children and says it affects more than 40% of American children. It also reports that untreated cavities lead thousands of young children to U.S. emergency departments annually, where the underlying dental problem often cannot be treated. Conventional dental procedures can be especially difficult for children who are too young to stay still or who are fearful or anxious. The trial's recruitment through dental, medical, and Head Start settings is relevant because those are places where children may be reached before dental pain escalates. The evidence reported here concerns a U.S. sample across three states, not a demonstration that every child or cavity will respond similarly.
Limits and unknowns
Silver diamine fluoride has been used to manage cavities in other countries for decades. In the United States, the source says the FDA approved SDF in 2014 as a medical device for tooth sensitivity, while use to stop cavities has been off-label. Limitations: the supplied account does not give the exact arrest percentage, adverse-event counts, follow-up duration, cavity-level predictors of response, or a direct comparison with fillings. Because more than half is not all treated teeth, the report does not establish that SDF will prevent later dental work, emergency visits, or surgery for every child; treated decay also turns permanently dark.
Follow the story
Share it, watch the explainer, or continue with the reporting trail.
Story timeline
FDA approval for tooth sensitivity
The supplied report says the FDA approved SDF as a medical device for treating tooth sensitivity; cavity-arrest use remained off-label.
Trial investigation begins
The supplied report says the multi-institution investigation began in 2018.
Further reading on this topic
2 links
U.S. trial finds silver diamine fluoride arrested decay in over half of treated baby teeth
A short visual explainer for readers who want the story in a different rhythm.
Highlights
- Decay arrested in over half of affected baby teeth
- 830 children under six took part
- Applied every six months
- An option while families arrange dental care
Transcript
A U.S. trial found silver diamine fluoride arrested decay in over half of affected baby teeth.
Researchers enrolled 830 children under six; clinicians painted the solution onto cavities with sponge tips.
Clinicians applied it every six months, without the drilling, injections or sedation some fillings require.
For some young children, it could stop cavities worsening while families arrange ongoing dental care.
An FDA application may follow; cavity arrest remains off-label, and the liquid doesn't rebuild teeth.